Abstract

Introduction The first case of the respiratory illness designated as Coronavirus Disease-2019 (COVID-19) in the United States was reported on January 22, 2020 near Seattle, Washington [1]. Since then, the United States has emerged as an epicenter of the COVID-19 pandemic, with more than 6.8 million cases and over 200,000 deaths

Highlights

  • Disease-2019 (COVID-19) in the United States was reported onThe first case of the respiratory illness designated as Coronavirus January 22, 2020 near Seattle, Washington [1]

  • people living with HIV (PLWH) may be at higher risk of morbidity and mortality related to COVID-19 than the general population because of underlying co-morbidities

  • All patients in the study cohort who died had an undetectable HIV viral load; this finding suggests that patients with uncontrolled HIV are not at a higher risk of mortality than patients with controlled HIV in the setting of COVID-19

Read more

Summary

Introduction

Disease-2019 (COVID-19) in the United States was reported onThe first case of the respiratory illness designated as Coronavirus January 22, 2020 near Seattle, Washington [1]. Disease-2019 (COVID-19) in the United States was reported on. United States has emerged as an epicenter of the COVID-19 that had end organ damage defined as one of the following pandemic, with more than 6.8 million cases and over 200,000 criteria: (i) acute kidney injury Severe disease inin the United States were living with HIV [5]. People living cluded patients that required non-invasive positive pressure with HIV (PLWH) may have an increased risk of poor outcomes ventilation (NIPPV) or mechanical ventilation with abnormal from COVID-19 because of underlying immunosuppression [6] chest radiograph findings or patients needing NC or NRB with and a high prevalence of co-morbidities [7]; limited end organ damage as defined above. Viral suppression concentrated in overlapping at-risk populations; it was defined as an HIV viral load

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call